04078nam a22007455i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350021001640350022001850400033002070410008002400440011002480720023002590820011002821000083002932450101003762640046004772640011005233000036005343360026005703370026005963380036006223470024006584900020006825050563007025060104012655200577013695300026019465380049019725460016020215880112020376500021021496500020021706500031021906500016022216500065022377730100023027730104024027730125025067730129026317760024027607760025027848560042028098560049028518560080029009120090029809120065030709120014031359120015031499120016031649120016031809120015031969120024032119120014032359120014032499120015032639120012032789120021032909120021033119783110702842DE-B159720221201113901.0m|||||o||d||||||||cr || ||||||||221201t20222022gw     fo  d z      eng d  a97831107028427 a10.1515/97831107028422doi  a(DE-B1597)549684  a(OCoLC)1312727016  aDE-B1597bengcDE-B1597erda0 aeng  agwcDE 7aTEC0090102bisacsh04a615.191 aMalhotra, Girish K., eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aActive Pharmaceutical Ingredient Manufacturing :bNondestructive Creation /cGirish K. Malhotra. 1aBerlin ;aBoston : bDe Gruyter, c[2022] 4c©2022  a1 online resource (XVI, 317 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aDe Gruyter STEM00tFrontmatter -- tPreface -- tContents -- tChapter 1 History of pharmaceuticals -- tChapter 2 Business model: brand versus generics, product demand, process selection, and economics -- tChapter 3 Physical and chemical properties -- tChapter 4 Pharma chemistry/chemical development -- tChapter 5 Manufacturing process development and case studies -- tChapter 6 Active pharmaceutical ingredients (API): innovation, design considerations, and waste reduction -- tChapter 7 Process documentation and operating strategies -- tChapter 8 Road Map -- tIndex0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aThe book reviews the history of current brand and generic business in pharmaceuticals manufacturing practices. Based on examples, the reader can interpolate, extrapolate and exploit mutual behavior (physical and chemical properties) of chemicals to design and commercialize processes that fulfi ll the demands, also manipulate chemical unit processes and unit operations to reduce/minimize effl uents and lower environmental impact i.e. reduce global warming. Readers will be able to simplify process development, design and commercialize economic manufacturing processes.  aIssued also in print.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 01. Dez 2022) 4aFeinchemikalien. 4aFormulierungen. 4aPharmazeutische Indutsrie. 4aWirkstoffe. 7aTechnology & Engineering / Chemical & Biochemical.2bisacsh08iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE COMPLETE 2022 Englishz978311099389908iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE COMPLETE 2022z9783110994810oZDB-23-DGG08iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE Physics, Chemistry, Mat.Sc, Geosc 2022 Englishz978311099344808iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE Physics, Chemistry, Mat.Sc, Geosc 2022z9783110993219oZDB-23-DPC0 cEPUBz97831107028970 cprintz978311070282840uhttps://doi.org/10.1515/978311070284240uhttps://www.degruyter.com/isbn/9783110702842423Coveruhttps://www.degruyter.com/document/cover/isbn/9783110702842/original  a978-3-11-099344-8  EBOOK PACKAGE Physics, Chemistry, Mat.Sc, Geosc 2022 Englishb2022  a978-3-11-099389-9  EBOOK PACKAGE COMPLETE 2022 Englishb2022  aEBA_DGALL  aEBA_EBKALL  aEBA_EEBKALL  aEBA_ESTMALL  aEBA_STMALL  aGBV-deGruyter-alles  aPDA12STME  aPDA13ENGE  aPDA18STMEE  aPDA5EBK  aZDB-23-DGGb2022  aZDB-23-DPCb2022